In a setback for Elon Musk's ambitious Neuralink - Brain Implant company, U.S. regulators have rejected Elon Musk’s bid to test brain chips in humans. The announcement was made by the U.S. Food and Drug Administration (FDA) on Monday.The decision comes as a blow to Musk's vision of merging human brains with artificial intelligence (AI) to enhance human cognitive abilities. Neuralink's technology involves implanting tiny devices into the brain that can communicate with computers, potentially allowing people to control machines with their thoughts and even communicate telepathically. Test Brain Chips on Humans
The FDA stated that Neuralink had not provided enough data to demonstrate the safety and efficacy of its devices in human trials. In a letter to Neuralink, the FDA said that the company's application "lacks sufficient information to support the initiation of the clinical investigation."The FDA's decision is a setback for Musk and Neuralink - Brain Implant company, who have been promoting the brain chip technology as a key part of their vision for a future where humans and machines merge. Musk has said that the technology could eventually help people with neurological conditions such as Parkinson's disease, but the company's initial focus is on creating a "brain-computer interface" for healthy individuals.Neuralink - Brain Implant company was founded by Musk in 2016, and the company has been working on its brain chip technology ever since. The company has reportedly conducted tests on animals, including monkeys, with promising results. However, the FDA's decision means that Neuralink - Brain Implant company will have to provide additional data before it can proceed with human trials.Musk has not yet commented on the FDA's decision, but he has previously said that he expects regulatory hurdles in developing the technology. In an interview with Joe Rogan in 2019, Musk said that "getting FDA approval for implantable devices is quite difficult."
Test Brain Chips on Humans
Despite the setback, Neuralink - Brain Implant company is likely to continue developing its brain chip technology. The company has raised more than $150 million in funding, and Musk has said that he will continue to invest in the project. However, the FDA's decision means that it may be some time before the brain chips are available for human useFor more updates keep visiting our website www.topstoriesworld.com where we provide unbiased, true and top stories of the world.